118 related articles for article (PubMed ID: 7377155)
41. Combined immune deficiency, autoantibody formation, and mucocutaneous candidiasis.
Provost TT; Garrettson LK; Zeschke RH; Rose NR; Tomasi TB
Clin Immunol Immunopathol; 1973 Jul; 1(4):429-45. PubMed ID: 4617643
[No Abstract] [Full Text] [Related]
42. Cell-mediated and humoral immune response to tetanus vaccinations in onchocerciasis patients.
Kilian HD; Nielsen G
Trop Med Parasitol; 1989 Sep; 40(3):285-91. PubMed ID: 2617034
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of cutaneous response to tetanus antigen to document immunization: preliminary observations.
Bhatia S; Ray K; Mathur R; Yadav TP; Rai Chowdhary AN; Grover SS; Narayanan I
Indian Pediatr; 1985 Apr; 22(4):267-73. PubMed ID: 3833747
[No Abstract] [Full Text] [Related]
44. Cell-mediated immunity in healthy and uremic adults assessed by in vivo and in vitro techniques. Validation of delayed hypersensitivity skin testing.
López M; Jerez J; González M; Arias M
Allergol Immunopathol (Madr); 1989; 17(1):21-8. PubMed ID: 2750637
[TBL] [Abstract][Full Text] [Related]
45. Effect of blood transfusion on the immune response of children with thalassaemia.
Kanakoudi-Tsakalidis F; Spyroglou K; Tzafi R; Cassimos C
Acta Haematol; 1977; 57(2):65-73. PubMed ID: 402767
[TBL] [Abstract][Full Text] [Related]
46. Responses to rubella, tetanus, and diphtheria vaccines in otitis-prone and non-otitis-prone children.
Prellner K; Harsten G; Löfgren B; Christenson B; Heldrup J
Ann Otol Rhinol Laryngol; 1990 Aug; 99(8):628-32. PubMed ID: 2382936
[TBL] [Abstract][Full Text] [Related]
47. Trans vivo analysis of human delayed-type hypersensitivity reactivity.
Carrodeguas L; Orosz CG; Waldman WJ; Sedmak DD; Adams PW; VanBuskirk AM
Hum Immunol; 1999 Aug; 60(8):640-51. PubMed ID: 10439310
[TBL] [Abstract][Full Text] [Related]
48. Adverse reactions to tetanus toxoid.
Jacobs RL; Lowe RS; Lanier BQ
JAMA; 1982 Jan; 247(1):40-2. PubMed ID: 7053439
[TBL] [Abstract][Full Text] [Related]
49. Subtle immunologic abnormalities in four boys with subacute sclerosing panencephalitis.
Gerson KL; Haslam RH
N Engl J Med; 1971 Jul; 285(2):78-82. PubMed ID: 4933967
[No Abstract] [Full Text] [Related]
50. Specific IgE and IgG4 immune responses to tetanus and diphtheria toxoid in atopic and nonatopic children during the first two years of life.
Dannemann A; van Ree R; Kulig M; Bergmann RL; Bauer P; Forster J; Guggenmoos-Holzmann I; Aalberse RC; Wahn U
Int Arch Allergy Immunol; 1996 Nov; 111(3):262-7. PubMed ID: 8917121
[TBL] [Abstract][Full Text] [Related]
51. Persistence of humoral immunity to tetanus and diphtheria in hematopoietic stem cell transplant recipients after post-transplant immunization.
Škovránková J; Petráš M
Pediatr Blood Cancer; 2012 Nov; 59(5):908-13. PubMed ID: 22514148
[TBL] [Abstract][Full Text] [Related]
52. ELISA detection of specific functional antibodies in human serum to Escherichia coli, tetanus toxoid, and diphtheria-tetanus toxoids: normal values for IgG, IgA, and IgM.
Moen RC; Oemichen SL; Kiggens AJ; Hong R
Diagn Immunol; 1986; 4(1):17-23. PubMed ID: 3514070
[TBL] [Abstract][Full Text] [Related]
53. Changes in non-specific immune responses induced by repeated delayed-type hypersensitivity skin testing with multiple antigens.
Lesourd BM; Winters WD; Kniker WT
J Clin Lab Immunol; 1986 Apr; 19(4):187-92. PubMed ID: 3723589
[TBL] [Abstract][Full Text] [Related]
54. [The vaccination of children with allergic diseases with reduced doses of adsorbed DT-m anatoxin].
Kostinov MP; Balabolkin II; Maksimova NM; Gervazieva VB; Egor'kov NA; Ovsiannikova IG; Lobanova AN
Pediatriia; 1991; (8):26-33. PubMed ID: 1762853
[TBL] [Abstract][Full Text] [Related]
55. Clinical and serologic responses to acellular pertussis vaccine in infants and young children.
Anderson EL; Belshe RB; Bartram J; Gurwith M; Hung P; Levner M; Vernon SK
Am J Dis Child; 1987 Sep; 141(9):949-53. PubMed ID: 3618569
[TBL] [Abstract][Full Text] [Related]
56. [The immunological basis of the administration of DTP-polio vaccine].
Cohen H
Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
[TBL] [Abstract][Full Text] [Related]
57. In vivo delayed-type hypersensitivity in 109 patients with vitiligo.
Behrens-Williams SC; Peters EM; Schallreuter KU
Int J Dermatol; 2000 Aug; 39(8):593-8. PubMed ID: 10971727
[TBL] [Abstract][Full Text] [Related]
58. Impaired cellular immunity in kwashiorkor with improvement after therapy.
Geefhuysen J; Rosen EU; Katz J; Ipp T; Metz J
Br Med J; 1971 Nov; 4(5786):527-9. PubMed ID: 5128206
[TBL] [Abstract][Full Text] [Related]
59. Potential protective immunogenicity of tetanus toxoid, diphtheria toxoid and Cross Reacting Material 197 (CRM197) when used as carrier proteins in glycoconjugates.
Bröker M
Hum Vaccin Immunother; 2016 Mar; 12(3):664-7. PubMed ID: 26327602
[TBL] [Abstract][Full Text] [Related]
60. Evidence for suppression or incomplete maturation of cell-mediated immunity in neonatal calves as determined by delayed-type hypersensitivity responses.
Rossi CR; Kiesel GK; Hudson RS; Powe TA; Fisher LF
Am J Vet Res; 1981 Aug; 42(8):1369-70. PubMed ID: 7294472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
